Načítá se...
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
PURPOSE OF REVIEW: Chronic lymphocytic leukaemia is now recognised as a heterogenous disease with a variety of clinical outcomes. Here we summarise the way it is currently stratified according to genetic risk and patient characteristics and the treatment approaches used for these different subgroups...
Uloženo v:
| Vydáno v: | Curr Oncol Rep |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072049/ https://ncbi.nlm.nih.gov/pubmed/32172299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-020-0893-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|